Briefly
By the order of the Minister of Health of Kazakhstan No. KR DSM-94 dated 5 September 2022 amendments were introduced to the Rules for Advertising of Medicines and Medical Devices (the "Rules").
In details
According to the amendments to the Rules, the National Scientific Center for Health Development named after Salidat Kairbekova will conduct an assessment of advertising of medicines and medical devices for compliance with Kazakhstan legislation requirements in the field of health care. Previously this activity was carried out by the National Center for Expertise of Medicines.
The amendments will take effect on September 22, 2022.
Are you interested in this topic?
- We would be pleased to discuss with you the above amendments and how they can impact your business;
- We can analyze and implement possible steps to ensure compliance with the new requirements.
If you are interested in additional information, please contact PwC specialists working as part of a group serving your company, or to any of the persons listed.
If you are interested in additional information, please contact us.
Contact us
